Early clinical experience with a novel self-expanding percutaneous stent-valve in the native right ventricular outflow tract

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 7, 2014, Pages 1131-1137

  Cao, Qi Ling ^a   Kenny, Damien ^a   Zhou, Daxin ^b   Pan, Wenzhi ^b   Guan, Lihua ^b   Ge, Junbo ^b   Hijazi, Ziyad M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

Adults; Congenital heart disease; Pediatrics; Percutaneous valve therapy; Surgery

Indexed keywords

ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DEVICE SAFETY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; FLUOROSCOPY; HEART REHABILITATION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PULMONARY ARTERY; PULMONARY VALVE INSUFFICIENCY; SELF EXPANDING PULMONARY VALVE; SELF EXPANDING STENT; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE; ADULT; AGED; ANIMAL; BIOPROSTHESIS; ECHOCARDIOGRAPHY; FOLLOW UP; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; MIDDLE AGED; PROCEDURES; PROSTHESIS; STENT; TIME; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

ADULT; AGED; ANIMALS; BIOPROSTHESIS; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; PULMONARY VALVE INSUFFICIENCY; STENTS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 84912051761     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25544     Document Type: Article

References (8)

1. Schievano S, Taylor AM, Capelli C, et al. First-in-man implantation of a novel percutaneous valve: A new approach to medical device development. EuroIntervention 2010;5:745-750.
2. Biglino G, Capelli C, Binazzi A, Reggiani R, Cosentino D, Migliavacca F, Bonhoeffer P, Taylor AM, Schievano S. Virtual and real bench testing of a new percutaneous valve device: A case study. Eurointervention 2012;8:120-128.
3. Schievano S, Coats L, Migliavacca F, et al. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: Implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson 2007;9:687- 695.
4. Cilingiroglu M, Salinger M, Zhao D, Feldman T. Technique of temporary subcutaneous "Figure-of-Eight" sutures to achieve hemostasis after removal of large-caliber femoral venous sheaths. Catheter Cardiovasc Interv 2011;78:155-160.
5. Kenny D, Hijazi ZM, Kar S, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: Early Phase 1 results from an International Multicenter Clinical Trial. J Am Coll Cardiol 2011;58:594-598.
6. McElhinney DB, Hellenbrand WE, et al. Short- And medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010;122: 507-516.
7. Momenah TS, El-Oakley R, Al-Najashi K, et al. Extended application of percutaneous pulmonary valve implantation. J Am Coll Cardiol 2009;53:1859-1863.
8. Guccione P, Milanesi O, Hijazi ZM, Pongiglione G. Transcatheter pulmonary valve implantation in native pulmonary outflow tract using the Edwards SAPIENTM transcatheter heart valve. Eur J Cardiothorac Surg 2012;41:1192-1194.